Number of Risk Factors in Down Syndrome Pregnancies

Deana J. Hussamy, Christina L. Herrera, Diane M. Twickler, Donald D. Mcintire, Jodi S. Dashe

Research output: Contribution to journalArticle

Abstract

Objective The objective of this study was to evaluate risk factor prevalence in pregnancies with fetal Down syndrome, in an effort to characterize efficacy of population-based screening. Study Design Retrospective review of singleton pregnancies with delivery of live born or stillborn infant with Down syndrome from 2009 through 2015. Risk factor categories included maternal age ≥35 years, abnormal serum screening, identification of ≥1 ultrasound marker at 16 to 22 weeks (nuchal thickness ≥6 mm, echogenic intracardiac focus, echogenic bowel, renal pelvis dilatation, femur length <third percentile), and detection of a major fetal anomaly. Statistical analyses included χ 2 test and Mantel–Haenszel χ 2 test. Results Down syndrome infants represented 1:428 singleton births. All risk categories were assessed in 125 pregnancies and included abnormal serum screen in 110 (88%), ≥1 ultrasound marker in 66 (53%), and ≥1 anomaly in 41 (34%). The calculated risk was at least 1:270 in 93% of Down syndrome pregnancies. More pregnancies had multiple risk factors than had a single risk factor, 90 (72%) versus 30 (24%), p < 0.001. An abnormal ultrasound marker or anomaly was identified in >50% of fetuses in women <35 years and in >75% of those 35 years and older. Conclusion In a population-based cohort, sensitivity of second-trimester Down syndrome screening was 93%, with multiple risk factors present in nearly three-fourths of cases.

Original languageEnglish (US)
JournalAmerican Journal of Perinatology
DOIs
StateAccepted/In press - Jul 17 2018

Fingerprint

Down Syndrome
Pregnancy
Echogenic Bowel
Kidney Pelvis
Maternal Age
Second Pregnancy Trimester
Femur
Population
Dilatation
Fetus
Retrospective Studies
Serum

Keywords

  • Down syndrome
  • serum aneuploidy screening
  • ultrasound markers

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology

Cite this

Number of Risk Factors in Down Syndrome Pregnancies. / Hussamy, Deana J.; Herrera, Christina L.; Twickler, Diane M.; Mcintire, Donald D.; Dashe, Jodi S.

In: American Journal of Perinatology, 17.07.2018.

Research output: Contribution to journalArticle

@article{9409b60b14a9435eb1d9af992986b819,
title = "Number of Risk Factors in Down Syndrome Pregnancies",
abstract = "Objective The objective of this study was to evaluate risk factor prevalence in pregnancies with fetal Down syndrome, in an effort to characterize efficacy of population-based screening. Study Design Retrospective review of singleton pregnancies with delivery of live born or stillborn infant with Down syndrome from 2009 through 2015. Risk factor categories included maternal age ≥35 years, abnormal serum screening, identification of ≥1 ultrasound marker at 16 to 22 weeks (nuchal thickness ≥6 mm, echogenic intracardiac focus, echogenic bowel, renal pelvis dilatation, femur length 2 test and Mantel–Haenszel χ 2 test. Results Down syndrome infants represented 1:428 singleton births. All risk categories were assessed in 125 pregnancies and included abnormal serum screen in 110 (88{\%}), ≥1 ultrasound marker in 66 (53{\%}), and ≥1 anomaly in 41 (34{\%}). The calculated risk was at least 1:270 in 93{\%} of Down syndrome pregnancies. More pregnancies had multiple risk factors than had a single risk factor, 90 (72{\%}) versus 30 (24{\%}), p < 0.001. An abnormal ultrasound marker or anomaly was identified in >50{\%} of fetuses in women <35 years and in >75{\%} of those 35 years and older. Conclusion In a population-based cohort, sensitivity of second-trimester Down syndrome screening was 93{\%}, with multiple risk factors present in nearly three-fourths of cases.",
keywords = "Down syndrome, serum aneuploidy screening, ultrasound markers",
author = "Hussamy, {Deana J.} and Herrera, {Christina L.} and Twickler, {Diane M.} and Mcintire, {Donald D.} and Dashe, {Jodi S.}",
year = "2018",
month = "7",
day = "17",
doi = "10.1055/s-0038-1666974",
language = "English (US)",
journal = "American Journal of Perinatology",
issn = "0735-1631",
publisher = "Thieme Medical Publishers",

}

TY - JOUR

T1 - Number of Risk Factors in Down Syndrome Pregnancies

AU - Hussamy, Deana J.

AU - Herrera, Christina L.

AU - Twickler, Diane M.

AU - Mcintire, Donald D.

AU - Dashe, Jodi S.

PY - 2018/7/17

Y1 - 2018/7/17

N2 - Objective The objective of this study was to evaluate risk factor prevalence in pregnancies with fetal Down syndrome, in an effort to characterize efficacy of population-based screening. Study Design Retrospective review of singleton pregnancies with delivery of live born or stillborn infant with Down syndrome from 2009 through 2015. Risk factor categories included maternal age ≥35 years, abnormal serum screening, identification of ≥1 ultrasound marker at 16 to 22 weeks (nuchal thickness ≥6 mm, echogenic intracardiac focus, echogenic bowel, renal pelvis dilatation, femur length 2 test and Mantel–Haenszel χ 2 test. Results Down syndrome infants represented 1:428 singleton births. All risk categories were assessed in 125 pregnancies and included abnormal serum screen in 110 (88%), ≥1 ultrasound marker in 66 (53%), and ≥1 anomaly in 41 (34%). The calculated risk was at least 1:270 in 93% of Down syndrome pregnancies. More pregnancies had multiple risk factors than had a single risk factor, 90 (72%) versus 30 (24%), p < 0.001. An abnormal ultrasound marker or anomaly was identified in >50% of fetuses in women <35 years and in >75% of those 35 years and older. Conclusion In a population-based cohort, sensitivity of second-trimester Down syndrome screening was 93%, with multiple risk factors present in nearly three-fourths of cases.

AB - Objective The objective of this study was to evaluate risk factor prevalence in pregnancies with fetal Down syndrome, in an effort to characterize efficacy of population-based screening. Study Design Retrospective review of singleton pregnancies with delivery of live born or stillborn infant with Down syndrome from 2009 through 2015. Risk factor categories included maternal age ≥35 years, abnormal serum screening, identification of ≥1 ultrasound marker at 16 to 22 weeks (nuchal thickness ≥6 mm, echogenic intracardiac focus, echogenic bowel, renal pelvis dilatation, femur length 2 test and Mantel–Haenszel χ 2 test. Results Down syndrome infants represented 1:428 singleton births. All risk categories were assessed in 125 pregnancies and included abnormal serum screen in 110 (88%), ≥1 ultrasound marker in 66 (53%), and ≥1 anomaly in 41 (34%). The calculated risk was at least 1:270 in 93% of Down syndrome pregnancies. More pregnancies had multiple risk factors than had a single risk factor, 90 (72%) versus 30 (24%), p < 0.001. An abnormal ultrasound marker or anomaly was identified in >50% of fetuses in women <35 years and in >75% of those 35 years and older. Conclusion In a population-based cohort, sensitivity of second-trimester Down syndrome screening was 93%, with multiple risk factors present in nearly three-fourths of cases.

KW - Down syndrome

KW - serum aneuploidy screening

KW - ultrasound markers

UR - http://www.scopus.com/inward/record.url?scp=85050260062&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050260062&partnerID=8YFLogxK

U2 - 10.1055/s-0038-1666974

DO - 10.1055/s-0038-1666974

M3 - Article

C2 - 30016823

AN - SCOPUS:85050260062

JO - American Journal of Perinatology

JF - American Journal of Perinatology

SN - 0735-1631

ER -